CEO-Letter 8

CEO-Letter 7

CEO-Letter 6

US progress and Nevisense Go

CEO-LETTER 5

7 April 2019 - Nevisense 3.0 and Skin Barrier application

CEO-LETTER 4

2 Nov 2017 - Updated strategy and securing our long-term capital needs

CEO-LETTER 3

April 2017 - Future trends and technologies

CEO-LETTER 2

January 2017 - Nevisense View: a new product with great potential

CEO-LETTER 1

December 2016: Teledermoscopy – good for increased awareness and access but is it good enough as a diagnostic method?